• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notice Inventory

  • Print
  • Share
  • E-mail

GRN No. 41

Martek Biosciences Corporation
6480 Dobbin Road; Columbia, MD 21045
Return to Listing
Substance:  DHASCO (docosahexaenoic acid-rich single-cell oil) and ARASCO (arachidonic acid-rich single-cell oil)
Intended Use:  Provide DHASCO (as a source of docosahexaenoic acid) and ARASCO (as a source of arachidonic acid) in term infant formula, at a maximum level of 1.25 percent each of the total dietary fat and at a ratio ranging from 1:1 to 1:2 (DHASCO:ARASCO)
Basis:  Scientific procedures
Date of filing:  01-MAR-00
Date of closure (select to view letter):  17-MAY-01
GRAS Notice (disclosable information):  GRN 41